Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Clonal Evolution of B Cells in High-risk CLL After Idelalisib-rituximab
ClinicalTrials.gov study NCT02993536. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Treatment With Targeted Therapies on the Generation of CAR T Cells in CLL Patients
ClinicalTrials.gov study NCT04640909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL
ClinicalTrials.gov study NCT02787369. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durabl
ClinicalTrials.gov study NCT06524375. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of the Metabolism in the Lymphatic Niche of CLL
ClinicalTrials.gov study NCT05610228. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04895436. IPD Sharing: YES. Countries: 11. Publications: 0.
Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL
ClinicalTrials.gov study NCT03502876. IPD Sharing: NO. Countries: 1. Publications: 0.
Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00464633. IPD Sharing: Not stated. Countries: 9. Publications: 0.
CLLR3: Bendamustine + GA101 (BG) in Relapsed or Refractory CLL Followed by GA101 Maintenance for Responding Patients
ClinicalTrials.gov study NCT02320383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
ClinicalTrials.gov study NCT01604031. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice
ClinicalTrials.gov study NCT03659669. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT06291220. IPD Sharing: NO. Countries: 5. Publications: 0.
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00086203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
ClinicalTrials.gov study NCT03422393. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial
ClinicalTrials.gov study NCT01127542. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00951457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL
ClinicalTrials.gov study NCT03271515. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLL
ClinicalTrials.gov study NCT00344786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04540796. IPD Sharing: YES. Countries: 8. Publications: 0.
Lenalidomide and Obinutuzumab for Previously Untreated CLL
ClinicalTrials.gov study NCT02371590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.